ronopterin
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2009 (NCT02012582)
Timeline
Indications
Mechanism of action
- Nitric-oxide synthase, brainINHIBITOR
NOS1 inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)nc(N)c2N1- Mol. weight
- 240.27 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL1230245 ↗
Also known as
- 2,4-diamino-5,6,7,8-tetrahydro-6(1,2-dihydroxypropyl)pteridine
- 4-amino-h4biopterin
- 4-amino-tetrahydrobiopterin
- ronopterin
- vas203
- vas203
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02794168 | Phase 3 | Jun 1, 2016 | ICON, Medical University Innsbruck, Vasopharm GmbH |
| NCT02992236 | Phase 1 | Aug 1, 2015 | Vasopharm GmbH, Winicker Norimed GmbH |
| NCT02012582 | Phase 2 | Nov 1, 2009 | Vasopharm GmbH |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vasopharm GmbH | For profit | 3 | 3 | 3 | 2009 |
| ICON | For profit | 1 | 0 | 1 | 2016 |
| Medical University Innsbruck | Academic/Hospital | 1 | 0 | 1 | 2016 |
| Winicker Norimed GmbH | For profit | 1 | 0 | 1 | 2015 |
4 organizations
Page 1 / 1